In a matter of huge relief for medicine manufacturer Bristol Myers Squibs, the Delhi High Court has upheld its patent over Dasatinib, a cancer drug. The Court accordingly rejected the petition of BDR Pharmaceuticals, an Indian company that had opposed the patent on the grounds that the same amounted to ever-greening.Evergreening is a concept under the law as per which patent holders try and...